Physician audiences
Mimetics models how groups of physicians interpret information and make decisions. BioVid says the models use its MindSet Modeling research, including surveys across medical specialties, together with secondary information about clinical practice. These are simulated research audiences, not recruited physicians answering a new study.
BioVid: Mimetics synthetic physician research announcement
Message, concept and segmentation research
The stated uses include testing messages and concepts, developing positioning, examining treatment drivers and barriers, exploring segments and assessing opportunities. A pharmaceutical team can use the modeled audience to explore how a proposed communication might be understood and which questions warrant further research with physicians.
BioVid: Mimetics synthetic physician research announcement
Managed studies and the segments app
BioVid offers studies using mimetic respondents alone or alongside human participants. The managed service includes a report and a research-team readout. A separate Mimetic Segments App lets client teams ask questions, share materials with modeled segments and return to those segments between research waves.
BioVid: Mimetics synthetic physician research announcement
Client research and customization
Models can be tailored using a client's primary research, segment profiles and customer relationship management data. BioVid says customized models are exclusive to that client and separated from other clients' models. Standard audiences are also offered, so a project does not always start with a new custom model.
BioVid: Mimetics synthetic physician research announcement
Published comparison and access
BioVid reports an 80–90% match between mimetic and human cohorts across content, reasoning and emotion in its parallel tests. The release does not supply the complete scoring protocol or test datasets. Managed mimetic fieldwork is described as taking one to two weeks after the required inputs are received, followed by reporting. Access is arranged with BioVid; a public price is not listed.
BioVid: Mimetics synthetic physician research announcement